| 10988454 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser +11 more |
2021-04-27 |
$6,947,000 |
| 10981890 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser +11 more |
2021-04-20 |
$7,328,000 |
| 10844041 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser +11 more |
2020-11-24 |
$4,510,000 |
| 10844042 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser +11 more |
2020-11-24 |
$4,510,000 |
| 10829473 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Nicolas Desroy, Gregory A. Gfesser +11 more |
2020-11-10 |
$9,537,000 |
| 10428017 |
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use |
Robert J. Altenbach, Andrew Bogdan, Nicolas Desroy, Gregory A. Gfesser, Stephen N. Greszler +9 more |
2019-10-01 |
$11,783,000 |
| 10399940 |
Substituted pyrrolidines and methods of use |
Robert J. Altenbach, Andrew Bogdan, Nicolas Desroy, Gregory A. Gfesser, Stephen N. Greszler +7 more |
2019-09-03 |
$13,935,000 |
| 10118916 |
Modulators of cystic fibrosis transmembrane conductance regulator protein |
Robert J. Altenbach, Andrew Bogdan, Vincent S. Chan, Timothy A. Grieme, John R. Koenig +8 more |
2018-11-06 |
$9,054,000 |
| 9981910 |
Substituted pyrrolidines and methods of use |
Robert J. Altenbach, Andrew Bogdan, Sylvain Couty, Elsa De Lemos, Nicolas Desroy +11 more |
2018-05-29 |
$7,623,000 |
| 9840513 |
Substituted tricyclics and method of use |
Robert J. Altenbach, Andrew Bogdan, Marlon D. Cowart, William Ramesh Esmieu, Gregory A. Gfesser +10 more |
2017-12-12 |
$5,899,000 |
| 9642831 |
Substituted chromanes and method of use |
Robert J. Altenbach, Andrew Bogdan, Stephen N. Greszler, John R. Koenig, Philip R. Kym +4 more |
2017-05-09 |
$6,038,000 |
| 9567322 |
Substituted tetrahydropyrans and method of use |
Philip R. Kym, Bo Liu, Xenia B. Searle, Xueqing Wang |
2017-02-14 |
$5,313,000 |
| 8937041 |
Macrocyclic hepatitis C serine protease inhibitors |
Keith F. McDaniel, Hui-Ju Chen, Timothy Middleton, Liangjun Lu, Kevin Kurtz |
2015-01-20 |
$146,470,000 |
| 8796470 |
Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators |
Xenia B. Searle, Michael R. Schrimpf |
2014-08-05 |
$63,281,000 |
| 8691865 |
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers |
Xenia B. Searle, Stanley DiDomenico, Andrew O. Stewart, Daria Darczak, Michael R. Schrimpf +1 more |
2014-04-08 |
$56,269,000 |
| 8653141 |
HIV protease inhibiting compounds |
Charles A. Flentge, Hui-Ju Chen, David A. DeGoey, William J. Flosi, David J. Grampovnik +8 more |
2014-02-18 |
$212,376,000 |
| 8497275 |
HCV protease inhibitors and uses thereof |
Brian E. Green, David D. Anderson, Todd D. Bosse, Curt S. Cooper, Larry L. Klein +10 more |
2013-07-30 |
$103,103,000 |
| 8193227 |
HIV protease inhibiting compounds |
Charles A. Flentge, Hui-Ju Chen, David A. DeGoey, William J. Flosi, David J. Grampovnik +8 more |
2012-06-05 |
$27,392,000 |
| 8129417 |
Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers |
Andrew O. Stewart, Xenia B. Searle, Daria Darczak, Stanley DiDomenico |
2012-03-06 |
$40,404,000 |
| 7902203 |
Anti-infective agents |
John K. Pratt, David A. Betebenner, Pamela L. Donner, Brian E. Green, Dale J. Kempf +14 more |
2011-03-08 |
$24,368,000 |
| 7834043 |
HIV protease inhibiting compounds |
David A. DeGoey, Charles A. Flentge, William J. Flosi, David J. Grampovnik, Dale J. Kempf +4 more |
2010-11-16 |
$23,054,000 |
| 7696226 |
HIV protease inhibiting compounds |
John T. Randolph, Hui-Ju Chen, David A. DeGoey, Charles A. Flentge, William J. Flosi +5 more |
2010-04-13 |
$223,815,000 |
| 7538105 |
Anti-infective agents |
Douglas K. Hutchinson, John Bellettini, David A. Betebenner, Richard D. Bishop, Thomas B. Borchardt +20 more |
2009-05-26 |
$85,478,000 |
| 7517876 |
Anti-infective agents |
Larry L. Klein, Peggy P. Huang, John T. Randolph, Douglas K. Hutchinson, Charles A. Flentge |
2009-04-14 |
$538,679,000 |
| 7378414 |
Anti-infective agents |
Douglas K. Hutchinson, John Bellettini, David A. Betebenner, Richard D. Bishop, Thomas B. Borchardt +20 more |
2008-05-27 |
$85,889,000 |
